ArticleBMC cancer2022

Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial.

Ching-Yun Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.